D

DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE (Private limited company)

BE 0828.298.539 Active ●Oude Staatsbaan 156, 9991 Maldegem

DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0828.298.539. It was founded on 05-08-2010. Its registered office is in Maldegem. Its main activity is: Human health activities. Its annual accounts for 2025 report equity of € 977 009 and a profit of € 166 200. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 0 of its last 4 financial years.

Information last updated on 20-10-2026.

Company information

Status
Active
Enterprise number
BE 0828.298.539
VAT registered
Yes
Founded
05-08-2010
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
Late for 2022, 2023, 2024, 2025
Peppol e-invoicing
Registered
Registered office
Oude Staatsbaan 156, 9991 Maldegem
Main activity
Human health activities
NACE activities
86210 Activités de médecine générale
72109 Recherche-développement en autres sciences physiques et naturelles

Key figures of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 166 200-14 %€ 192 188+8 %€ 178 087+63 %€ 108 932
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 977 009-4 %€ 1 020 531+23 %€ 828 342+22 %€ 677 251
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 735 161-5 %€ 1 824 623+9 %€ 1 681 284+8 %€ 1 551 960
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 356 216-11 %€ 401 011+17 %€ 343 309+52 %€ 226 306
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Maldegem.

Looking for more information about DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE still active? Yes. The Crossroads Bank for Enterprises lists DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE as active.

What is the VAT number of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE? The VAT number of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is BE 0828.298.539.

When was DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE founded? DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE was founded on 05-08-2010.

What is the address of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE? The current registered office of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is Oude Staatsbaan 156, 9991 Maldegem.

When did DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE last file annual accounts? The latest annual accounts of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE were filed on 25-09-2026.

Does DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE file its annual accounts on time? DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE filed its annual accounts within the legal deadline for 0 of its last 4 financial years. Late: 2022, 2023, 2024, 2025.

Is DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE financially healthy? Addrly gives DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE profitable? The annual accounts of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE for 2025 show a profit of € 166 200.

What is the equity of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE? The equity of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE was € 977 009 at the close of the 2025 financial year.

Who are the directors of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE? The annual accounts of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE record 2 mandates. The names, roles and dates are visible with a free account.

Can DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE receive Peppol e-invoices? Yes. DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is registered on the Peppol network and can receive structured electronic invoices.

What does DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE do? The main activity of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is: Human health activities.

Sources

How Addrly builds and refreshes this data